Genscript Biotech Corporation (Stock Code: 01548) published the monthly return on movements in securities for the month ended 30 November 2025. The authorized share capital remained at USD 5,000,000, with no change in the total of 5,000,000,000 authorized shares.

The number of issued shares increased from 2,185,678,939 to 2,186,218,520, representing a net rise of 539,581 shares. Among these, 50,000 new shares were issued under the post-IPO share option scheme, raising HKD 350,740 in total. Another 489,581 new shares were issued in respect of share awards at a price of HKD 0.00778 per share. No changes occurred in treasury shares, warrants, convertible securities, or other issuance arrangements during the reporting period.

The information was submitted on 02 December 2025 by a director of Genscript Biotech Corporation and reflects compliance with relevant Hong Kong Stock Exchange requirements.